News Releases

Orgenesis to Present at the 16th Annual B. Riley Investor Conference
May 07, 2015

Investment Fund Manager, Chris Buyse, Appointed to Orgenesis Board
Apr 16, 2015

CEO of MaSTherCell, Hugues Bultot, Joins Orgenesis Board of Directors
Apr 15, 2015

Orgenesis Signs Cell Therapy Product Development Memorandum of Understanding with CureCell of Korea
Apr 08, 2015

Orgenesis to Collaborate with the Global Stem Cell & Regenerative Medicine Acceleration Center of Korea
Apr 07, 2015

Orgenesis Appoints Prof. Itamar Raz as Newest Member of Board of Advisors
Mar 16, 2015

Orgenesis Acquires Cell Therapy Manufacturer MaSTherCell
Mar 09, 2015

Orgenesis Approved for EUR 2.015.000 Grant to Support Development of its Type 1 Diabetes Program in Europe
Nov 24, 2014

Orgenesis Receives Patent for Potential Cure for Type 1 Diabetes
Oct 15, 2014

Scott Carmer Named as CEO of Orgenesis North America
Aug 05, 2014



RSS Feed

icon-rss Preview or subscribe to our news feed here.


Historical Press Releases

This website contains historical and archived press releases for Orgenesis Inc. The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Orgenesis Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

Back to Top